Literature DB >> 2585246

Introduction of HIV infection among intravenous drug abusers in low prevalence areas.

R J Battjes1, R W Pickens, Z Amsel.   

Abstract

To explore the introduction of human immunodeficiency virus (HIV) infection into intravenous drug abusing populations, risk behaviors of 1,154 intravenous drug abusers (IVDAs) in four U.S. cities with low prevalence of IVDA/HIV infection (0.9-13.0%) were examined. Seropositive subjects (N = 54) were compared with demographically matched seronegative controls regarding drug use practices, homosexual contact, blood transfusions, risk behaviors while traveling or living in high prevalence areas, and acquaintance with persons with AIDS. With the exception of needle sharing with homosexual/bisexual males, no differences in risk behaviors were found between seropositive subjects and matched seronegatives. Seropositives were substantially more likely than matched seronegatives to report having shared a needle with a homosexual or bisexual male, suggesting that needle sharing between homosexual/bisexual IVDAs and heterosexual IVDAs may be an important means by which HIV is introduced among heterosexual IVDAs in low prevalence areas.

Entities:  

Mesh:

Year:  1989        PMID: 2585246

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  4 in total

1.  Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

Authors:  S R Friedman; T Perlis; D C Des Jarlais
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

2.  Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.

Authors:  J López-Zetina; W Ford; M Weber; S Barna; T Woerhle; P Kerndt; E Monterroso
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

3.  Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.

Authors:  F Lamothe; J Bruneau; R Coates; J G Rankin; J Soto; R Arshinoff; M Brabant; J Vincelette; M Fauvel
Journal:  CMAJ       Date:  1993-10-01       Impact factor: 8.262

4.  HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest.

Authors:  H A Siegal; R G Carlson; R Falck; L Li; M A Forney; R C Rapp; K Baumgartner; W Myers; M Nelson
Journal:  Am J Public Health       Date:  1991-12       Impact factor: 9.308

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.